contributory < control < controling

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by control

Number of relevant bibliographic references: 623.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000003 (2020)	B. Ye [République populaire de Chine] ; C. Fan [République populaire de Chine] ; Y. Pan [République populaire de Chine] ; R. Ding [République populaire de Chine] ; H X Hu [République populaire de Chine] ; M L Xiang [République populaire de Chine]	[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]
000011 (2020)	Rong-Sheng Luan [République populaire de Chine] ; Xin Wang [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Xing-Shu Chen [République populaire de Chine] ; Tao Zhou [République populaire de Chine] ; Quan-Hui Liu [République populaire de Chine] ; Xin Lü [République populaire de Chine] ; Xian-Ping Wu [République populaire de Chine] ; Dong-Qing Gu [République populaire de Chine] ; Ming-Shuang Tang [République populaire de Chine] ; Hui-Jie Cui [République populaire de Chine] ; Xue-Feng Shan [République populaire de Chine] ; Jing Ouyang [République populaire de Chine] ; Ben Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Emergency Research Group Sichuan University Covid- [République populaire de Chine]	[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].
000012 (2020)	E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique]	[Coronavirus and COVID-19 : focus on a galopping pandemic].
000013 (2020)		[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
000014 (2020)		[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
000019 (2020)	H Y Tian [République populaire de Chine]	[2019-nCoV: new challenges from coronavirus].
000026 (2020)	Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine]	Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
000030 (2020)	Yixuan Wang [République populaire de Chine] ; Yuyi Wang [République populaire de Chine] ; Yan Chen [République populaire de Chine] ; Qingsong Qin [République populaire de Chine]	Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
000040 (2020)	Chang Hoon Yang ; Hyejin Jung	Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks
000048 (2020)	Hussin A. Rothan [États-Unis] ; Siddappa N. Byrareddy [États-Unis]	The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
000053 (2020)	Maged Gomaa Hemida [Arabie saoudite] ; Mohammed M. Ba Abduallah [Arabie saoudite]	The SARS-CoV-2 outbreak from a one health perspective.
000059 (2020)		The Impact and Control of Emerging and Re-Emerging Viral Diseases in the Environment: An African Perspective
000063 (2020)	Pranab Chatterjee [Inde] ; Nazia Nagi [Inde] ; Anup Agarwal [Inde] ; Bhabatosh Das [Inde] ; Sayantan Banerjee [Inde] ; Swarup Sarkar [Inde] ; Nivedita Gupta [Inde] ; Raman R. Gangakhedkar [Inde]	The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence.
000066 (2020)	Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine]	Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
000076 (2020)	Khalid Al-Ahmadi [Arabie saoudite] ; Mohammed Alahmadi [Arabie saoudite] ; Ali Al-Zahrani [Arabie saoudite]	Spatial association between primary Middle East respiratory syndrome coronavirus infection and exposure to dromedary camels in Saudi Arabia.
000077 (2020)	Isabel Ortiz De Solorzano [Espagne] ; Karteek K. Bejagam ; Yaxin An ; Samrendra K. Singh ; Sanket A. Deshmukh	Solvation dynamics of N-substituted acrylamide polymers and the importance for phase transition behavior.
000088 (2020)	Janko Nikolich-Zugich [États-Unis] ; Kenneth S. Knox [États-Unis] ; Carlos Tafich Rios [États-Unis] ; Bhupinder Natt [États-Unis] ; Deepta Bhattacharya [États-Unis] ; Mindy J. Fain [États-Unis]	SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
000095 (2020)	Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada]	Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
000097 (2020)	Shuntong Kang [République populaire de Chine] ; Wenyao Peng [République populaire de Chine] ; Yuhao Zhu [République populaire de Chine] ; Shiyao Lu [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Wenfang Wu [République populaire de Chine] ; Shu Huang [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Meichun Deng [République populaire de Chine]	Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment
000101 (2020)	Barbara Nussbaumer-Streit ; Verena Mayr ; Andreea Iulia Dobrescu ; Andrea Chapman ; Emma Persad ; Irma Klerings ; Gernot Wagner ; Uwe Siebert [Autriche] ; Claudia Christof ; Casey Zachariah ; Gerald Gartlehner	Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
000107 (2020)	Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine]	Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "control" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "control" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    control
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021